Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children

Eur J Clin Pharmacol. 2009 Aug;65(8):849-50; author reply 851-2. doi: 10.1007/s00228-009-0655-2. Epub 2009 Apr 25.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Age Factors
  • Child
  • Child Development*
  • Clinical Trials as Topic* / standards
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Approval*
  • Humans
  • Models, Statistical*
  • Proton Pump Inhibitors / therapeutic use

Substances

  • Proton Pump Inhibitors